PIK3CA and breast neoplasm: 5-Fold cross-validation achieved an accuracy of 69.7% (sensitivity = 84.4%, specificity = 41.7%) pointing to factors other than PIK3CA genotype that could affect ω6 FA levels in breast tumor tissue.